AI assistant
Sending…
ASSEMBLY BIOSCIENCES, INC. — Director's Dealing 2024
Oct 4, 2024
33081_dirs_2024-10-04_43881d11-741a-43bf-8ff8-ebef536c2c78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2024-10-03
Reporting Person: White Nicole S (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-10-03 | Common Stock | S | 157 | $14.81 | Disposed | 11911 | Direct |
Footnotes
F1: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person.
More from ASSEMBLY BIOSCIENCES, INC.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Mar 19
Major Shareholding Notification
2026
Feb 9
Regulatory Filings
2025
Dec 8
Regulatory Filings
2025
Nov 21